New developments in the diagnosis and treatment of thyroid cancer
DF Schneider, H Chen - CA: a cancer journal for clinicians, 2013 - Wiley Online Library
Answer questions and earn CME/CNE Thyroid cancer exists in several forms. Differentiated
thyroid cancers include those with papillary and follicular histologies. These tumors exist …
thyroid cancers include those with papillary and follicular histologies. These tumors exist …
Growing incidence of thyroid carcinoma in recent years: factors underlying overdiagnosis
There is an increasing incidence of well‐differentiated thyroid cancer worldwide. Much of the
increase is secondary to increased detection of small, low‐risk tumors, with questionable …
increase is secondary to increased detection of small, low‐risk tumors, with questionable …
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer
Background It is not known whether low-dose radioiodine (1.1 GBq [30 mCi]) is as effective
as high-dose radioiodine (3.7 GBq [100 mCi]) for treating patients with differentiated thyroid …
as high-dose radioiodine (3.7 GBq [100 mCi]) for treating patients with differentiated thyroid …
The Increase in Thyroid Cancer Incidence During the Last Four Decades Is Accompanied by a High Frequency of BRAF Mutations and a Sharp Increase in RAS …
Context: Thyroid cancer incidence rates in the United States and globally have increased
steadily over the last 40 years, primarily due to a tripling of the incidence of papillary thyroid …
steadily over the last 40 years, primarily due to a tripling of the incidence of papillary thyroid …
A worldwide journey of thyroid cancer incidence centred on tumour histology
Over the past three decades, the incidence of thyroid carcinoma has been increasing
globally. Data from 2006 to 2012 indicate an annual incidence rate of thyroid cancer of …
globally. Data from 2006 to 2012 indicate an annual incidence rate of thyroid cancer of …
Should all papillary thyroid microcarcinomas be aggressively treated?: an analysis of 18,445 cases
Objective: The purpose of this study was to identify the risk factors that predict papillary
thyroid microcarcinoma (PTMC)-related death in a large patient population to determine …
thyroid microcarcinoma (PTMC)-related death in a large patient population to determine …
An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC/UICC staging system for well-differentiated thyroid cancer
Background: Age is a critical factor in outcome for patients with well-differentiated thyroid
cancer. Currently, age 45 years is used as a cutoff in staging, although there is increasing …
cancer. Currently, age 45 years is used as a cutoff in staging, although there is increasing …
Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years
RW Randle, CJ Balentine, GE Leverson, JA Havlena… - Surgery, 2017 - Elsevier
Background The impact of recent medical advances on disease presentation, extent of
operation, and disease-specific survival for patients with medullary thyroid cancer is unclear …
operation, and disease-specific survival for patients with medullary thyroid cancer is unclear …
Thyroid cancer incidence trends in the United States: association with changes in professional guideline recommendations
M Pereira, VL Williams, J Hallanger Johnson… - Thyroid, 2020 - liebertpub.com
Background: Overdiagnosis is the leading factor contributing to the rapid increase in thyroid
cancer incidence of the last decades. During this period, however, thyroid cancer incidence …
cancer incidence of the last decades. During this period, however, thyroid cancer incidence …
Cytological features of “noninvasive follicular thyroid neoplasm with papillary-like nuclear features” and their correlation with tumor histology
F Maletta, F Massa, L Torregrossa, E Duregon… - Human pathology, 2016 - Elsevier
Among thyroid papillary carcinomas (PTCs), the follicular variant is the most common and
includes encapsulated forms (EFVPTCs). Noninvasive EFVPTCs have very low risk of …
includes encapsulated forms (EFVPTCs). Noninvasive EFVPTCs have very low risk of …